Cutaneous tuberculosis, different clinical spectrum of the same disease: the importance of pre-test probability


Submitted: 12 June 2023
Accepted: 16 July 2023
Published: 24 January 2024
Abstract Views: 1112
PDF: 323
HTML: 28
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

This report presents three cases of cutaneous tuberculosis that were identified at the Calderon Hospital in Quito, Ecuador. The first case involved a 44-year-old man who had tuberculosis verrucosa cutis, characterized by circinate erythematous areas, ulcerated nodules, and verruciform plaques extending from the right lower limb to the hip. In the second case a 50-year-old woman with a 1-year history of pruritic dermatosis in the left ciliary area was diagnosed with lupus vulgaris. In the third case, a 23-year-old man with erythematous nodules draining caseous material at the neck, thorax, and axillary region was diagnosed with scrofuloderma. It was discovered that nearly every laboratory test that was accessible had drawbacks as a diagnostic technique. Correlating clinical and epidemiological features with the pretest probability is crucial for optimizing indicators and confirming or ruling out the diagnosis in immunocompromised and high-risk individuals with atypical lesions.


World Health Organization. Global Tuberculosis Report 2021. 2021:7. Available from: https://www.who.int/publications/i/item/9789240037021

Khadka P, Koirala S, Thapaliya J. Cutaneous tuberculosis: clinicopathologic arrays and diagnostic challenges. Dermatol Res Pract 2018;2018.

Vignesh N, Sangaiah S, Kumar AN, Salam A. Cutaneous tuberculosis-one diagnosis, a plethora of differentials. J Clin Diagnostic Res 2022;16:1-5.

Afsar I, Afsar FS. Evaluation of laboratory diagnosis for cutaneous tuberculosis. Indian J Pathol Microbiol 2016;59:274-8.

Pebriany D, Anwar AI, Djamaludin W, et al. Successful diagnosis and management of tuberculosis verrucosa cutis using antituberculosis therapy trial approach. Pan Afr Med J 2020;37:1-8.

Kocagoz T, O’Brien R, Perkins M, Baylan O. A new colorimetric culture system for the diagnosis of tuberculosis [3] (multiple letters). Int J Tuberc Lung Dis 2004;8.

de Brito AC, de Oliveira CMM, Unger DAA, de Bittencourt MJS. Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic update. An Bras Dermatol 2022; 97:129-44.

Connell TG, Rangaka MX, Curtis N, Wilkinson RJ. QuantiFERON-TB Gold: State of the art for the diagnosis of tuberculosis infection? Expert Rev Mol Diagn 2006;6.

Jusuf Fantoni OJ, Ary. ani IA. Histopathological Features of Cutaneous Tuberculoid Granuloma Disorders. Biosci Med J Biomed Transl Res 2021;5:825-36.

Ministerio de Salud Pública del Ecuador. Prevención, diagnóstico, tratamiento y control de la tuberculosis. Guia de Práctica Clínica. 2018.

World Health Organization. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIVprevalent and resource constrained settings. 2007. Available from: https://iris.who.int/handle/10665/69463

Van Zyl L, Du Plessis J, Viljoen J. Cutaneous tuberculosis overview and current treatment 238 regimens. Tuberculosis 2015;95.

Pai V, Naveen K, Athanikar S, et al. A clinico-histopathological study of lupus vulgaris: a 3 year experience at a tertiary care centre. Indian Dermatol Online J 2014;5.

Vural S, Unlu E, Karaosmanoglu N, et al. A giant mass on the scalp: an unusual presentation of lupus vulgaris. Int J Dermatol 2019;58.

Behar SM, Martin CJ, Booty MG, et al. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunol 2011;4.

Frankel A, Penrose C, Emer J. Cutaneous tuberculosis: a practical case report and review for the dermatologist. J Clin Aesthet Dermatol 2009;2.

Gunawan H, Achdiat PA, Hindritiani R, et al. Various cutaneous tuberculosis with rare clinical manifestations: A case series. Int J Mycobacteriol 2018;7.

Behr MA, Warren SA, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999;353.

Sester M, Sotgiu G, Lange C, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011;37.

Sarmiento OL, Weigle KA, Alexander J, et al. Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J Clin Microbiol 2003;41.

Carla Rosero, Dermatology Postgraduate, Faculty of Medical Sciences, Central University of Ecuador; Department of Dermatology, Calderón General Hospital, Quito

 

 

 

Lucy Baldeón, Biomedicine Research Institute, Central University of Ecuador; Faculty of Medical Sciences, Central University of Ecuador, Quito

 

 

 

Adriana Rueda, Biomedicine Research Institute, Central University of Ecuador, Quito

 

 

 

Lorena Vaca, Department of Dermatology, Calderón General Hospital, Quito

 

 

Daniela Galarza, Department of Dermatology, Calderón General Hospital, Quito

 

 

 

Cesar Prócel, Internal Medicine Department, Metropolitan Hospital, Quito

 

 

Rosero, C., Baldeón, L., Alulema, V., Rueda, A., Vaca, L., Galarza, D., & Prócel, C. (2024). Cutaneous tuberculosis, different clinical spectrum of the same disease: the importance of pre-test probability. Dermatology Reports, 16(2). https://doi.org/10.4081/dr.2024.9770

Downloads

Download data is not yet available.

Citations